Chiba, Shigeru
Mito Saiseikai General Hospital,
Japan
2025 Rank: 81425
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1509 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81425 | 84756 |
| Total Cites | 1107 | 1261 |
| H-index | 15 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 43 | 43 |
| Number of Single+First+Last Authored Papers | 115 | 115 |
| Total Cites to Single+First+Last Authored Papers | 228 | 238 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 986 | 1108 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
12.21%
|
|
Chiba, Shigeru
University of Tsukuba,
Japan
2024 Rank: 60068
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1202 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60068 | 62979 |
| Total Cites | 1191 | 1361 |
| H-index | 15 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 59 | 60 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 286 | 302 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1002 | 1136 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
12.49%
|
|
Chiba, Shigeru
Faculty of Medicine, University of Tsukuba,
Japan
2023 Rank: 70134
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1561 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70134 | 73605 |
| Total Cites | 1102 | 1275 |
| H-index | 13 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 50 | 50 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 241 | 247 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 947 | 1094 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.17 |
| Self-Citation Percentage |
13.57%
|
|
Chiba, Shigeru
University of Tsukuba,
Japan
2022 Rank: 51118
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1284 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51118 | 56573 |
| Total Cites | 1022 | 1132 |
| H-index | 15 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 51 | 53 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 241 | 258 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 859 | 937 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.21 |
| Self-Citation Percentage |
9.72%
|
|
Chiba, Shigeru
Faculty of Medicine, University of Tsukuba,
Japan
2021 Rank: 63867
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1449 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63867 | 64165 |
| Total Cites | 1467 | 1646 |
| H-index | 17 | 18 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 28 | 28 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 51 | 53 |
| Number of Single+First+Last Authored Papers | 105 | 105 |
| Total Cites to Single+First+Last Authored Papers | 351 | 383 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1228 | 1337 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.23 |
| Self-Citation Percentage |
10.87%
|
|
Chiba, Shigeru
University of Tsukuba,
Japan
2020 Rank: 74351
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1561 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74351 | 74177 |
| Total Cites | 1015 | 1142 |
| H-index | 13 | 14 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 25 | 26 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 32 | 33 |
| Number of Single+First+Last Authored Papers | 100 | 100 |
| Total Cites to Single+First+Last Authored Papers | 263 | 280 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 864 | 947 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.21 |
| Self-Citation Percentage |
11.12%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.